Card | Table | RUSMARC | |
Advances in Alzheimer's disease (Series) ;.
|
Document access rights
Network | User group | Action | ||||
---|---|---|---|---|---|---|
Finuniversity Local Network | All | |||||
Internet | Readers | |||||
Internet | Anonymous |
Table of Contents
- Title Page
- Preface
- Contents
- Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future
- Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment
- Lost in Translation? Finding Our Way To Effective Alzheimer's Disease Therapies
- The End of the Beginning of the Alzheimer's Disease Nightmare: A Devil's Advocate's View
- Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology
- Multifactorial Hypothesis and Multi-Targets for Alzheimer's Disease
- Dementia Research: Populations, Progress, Problems, and Predictions
- Three Decades of Dementia Research: Insights from One Small Community of Indomitable Rotterdammers
- Religious Orders Study and Rush Memory and Aging Project
- Prevention Matters: Time for Global Action and Effective Implementation
- Multimodal Neuroimaging in Alzheimer's Disease: Early Diagnosis, Physiopathological Mechanisms, and Impact of Lifestyle
- Preclinical Alzheimer's Disease: Implications for Refinement of the Concept
- Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review
- The Relationship between Obstructive Sleep Apnea and Alzheimer's Disease
- From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer's Disease
- Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial Enrichment
- A Blood Test for Alzheimer's Disease: Progress, Challenges, and Recommendations
- Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease
- Brain Inflammation Connects Cognitive and Non-Cognitive Symptoms in Alzheimer's Disease
- Toward a New Concept of Alzheimer's Disease Models: A Perspective from Neuroinflammation
- Role of Neuroinflammation in the Trajectory of Alzheimer's Disease and in vivo Quantification Using PET
- Microglial Activation During Pathogenesis of Tauopathy in rTg4510 Mice: Implications for the Early Diagnosis of Tauopathy
- Conquering Alzheimer's Disease by Self Treatment
- Past to Future: What Animal Models Have Taught Us About Alzheimer's Disease
- Iron and Alzheimer's Disease: An Update on Emerging Mechanisms
- Brain Aging and Late-Onset Alzheimer's Disease: A Matter of Increased Amyloid or Reduced Energy?
- Metabolic Dysfunction in Alzheimer's Disease: From Basic Neurobiology to Clinical Approaches
- Targeting Insulin for Alzheimer's Disease: Mechanisms, Status and Potential Directions
- Mitochondrial Function, Dynamics, and Permeability Transition: A Complex Love Triangle as A Possible Target for the Treatment of Brain Aging and Alzheimer's Disease
- Perspectives on Oxidative Stress in Alzheimer's Disease and Predictions of Future Research Emphases
- Novel Key Players in the Development of Tau Neuropathology: Focus on the 5-Lipoxygenase
- Findings from the Swedish Study on Familial Alzheimer's Disease Including the APP Swedish Double Mutation
- Untold New Beginnings: Adult Hippocampal Neurogenesis and Alzheimer's Disease
- Our Tau Tales from Normal to Pathological Behavior
- Amyloid-Beta and Tau in Alzheimer's Disease: Novel Pathomechanisms and Non-Pharmacological Treatment Strategies
- New Beginnings in Alzheimer's Disease: The Most Prevalent Tauopathy
- Tau Conformation as a Target for Disease-Modifying Therapy: The Role of Truncation
- The Conundrum of GSK3 Inhibitors: Is it the Dawn of a New Beginning?
- Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Progress and Potential Pitfalls
- The Amyloid-Beta Oligomer Hypothesis: Beginning of the Third Decade
- Role of Amyloid-Beta and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade
- Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer's Disease
- Underlying Biological Processes in Mild Cognitive Impairment: Amyloidosis Versus Neurodegeneration
- Amyloid-Beta/Drug Interactions from Computer Simulations and Cell-Based Assays
Usage statistics
Access count: 0
Last 30 days: 0 Detailed usage statistics |